PortalPublikationenLate life schizophrenia and its treatment: pharmacologic iss...

Late life schizophrenia and its treatment: pharmacologic issues in older schizophrenic patients.

Standard

Late life schizophrenia and its treatment: pharmacologic issues in older schizophrenic patients. / Tran-Johnson, T K; Krüll, Andreas; Jeste, D V.

in: CLIN GERIATR MED, Jahrgang 8, Nr. 2, 2, 1992, S. 401-410.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Tran-Johnson, TK, Krüll, A & Jeste, DV 1992, 'Late life schizophrenia and its treatment: pharmacologic issues in older schizophrenic patients.', CLIN GERIATR MED, Jg. 8, Nr. 2, 2, S. 401-410. <http://www.ncbi.nlm.nih.gov/pubmed/1350940?dopt=Citation>

APA

Tran-Johnson, T. K., Krüll, A., & Jeste, D. V. (1992). Late life schizophrenia and its treatment: pharmacologic issues in older schizophrenic patients. CLIN GERIATR MED, 8(2), 401-410. [2]. http://www.ncbi.nlm.nih.gov/pubmed/1350940?dopt=Citation

Vancouver

Tran-Johnson TK, Krüll A, Jeste DV. Late life schizophrenia and its treatment: pharmacologic issues in older schizophrenic patients. CLIN GERIATR MED. 1992;8(2):401-410. 2.

Bibtex

@article{6b6df94c5333402bbf2f5874c9ee0895,
title = "Late life schizophrenia and its treatment: pharmacologic issues in older schizophrenic patients.",
abstract = "Schizophrenia in late life includes both chronic early-onset schizophrenia and late-onset schizophrenia. Treatment with neuroleptics in relatively low doses is often useful in controlling psychotic symptoms in these patients. The value of neuroleptics is limited, however, by the risks of side effects such as tardive dyskinesia.",
keywords = "Humans, Aged, Time Factors, Schizophrenia/*drug therapy, Aging/metabolism/*psychology, Antipsychotic Agents/pharmacokinetics/pharmacology/*therapeutic use, Humans, Aged, Time Factors, Schizophrenia/*drug therapy, Aging/metabolism/*psychology, Antipsychotic Agents/pharmacokinetics/pharmacology/*therapeutic use",
author = "Tran-Johnson, {T K} and Andreas Kr{\"u}ll and Jeste, {D V}",
year = "1992",
language = "English",
volume = "8",
pages = "401--410",
number = "2",

}

RIS

TY - JOUR

T1 - Late life schizophrenia and its treatment: pharmacologic issues in older schizophrenic patients.

AU - Tran-Johnson, T K

AU - Krüll, Andreas

AU - Jeste, D V

PY - 1992

Y1 - 1992

N2 - Schizophrenia in late life includes both chronic early-onset schizophrenia and late-onset schizophrenia. Treatment with neuroleptics in relatively low doses is often useful in controlling psychotic symptoms in these patients. The value of neuroleptics is limited, however, by the risks of side effects such as tardive dyskinesia.

AB - Schizophrenia in late life includes both chronic early-onset schizophrenia and late-onset schizophrenia. Treatment with neuroleptics in relatively low doses is often useful in controlling psychotic symptoms in these patients. The value of neuroleptics is limited, however, by the risks of side effects such as tardive dyskinesia.

KW - Humans

KW - Aged

KW - Time Factors

KW - Schizophrenia/drug therapy

KW - Aging/metabolism/psychology

KW - Antipsychotic Agents/pharmacokinetics/pharmacology/therapeutic use

KW - Humans

KW - Aged

KW - Time Factors

KW - Schizophrenia/drug therapy

KW - Aging/metabolism/psychology

KW - Antipsychotic Agents/pharmacokinetics/pharmacology/therapeutic use

M3 - SCORING: Journal article

VL - 8

SP - 401

EP - 410

IS - 2

M1 - 2

ER -